Wait, are we taking a break from aspirin? While so much of our conversations around health is rightly focused on Covid-19, there are other health developments to discuss with our medical providers.

Low-dose aspirin use was linked to a 55% lower risk of colorectal cancer recurrence in people with a genetic mutation that ...

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin,” researchers ...

Research highlights aspirin’s potential in lowering tumor return by 50% in patients with specific genetic mutations - Anadolu ...

Study in JAMA Oncology: aspirin may cut cancer risk for some adults over 70 and raise it for others. Genetics, smoking, and BMI help guide decisions.

Taking daily low-dose aspirin could almost halve the risk of colorectal cancer recurrence for some patients whose tumors have ...

A new study finds that the common over-the-counter medication Aspirin could significantly cut the risk of colorectal cancer ...

A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic ...

If you're over the age of 60, you've likely seen headlines in the last couple of years warning against previous medical advice to take aspirin as a preventative measure against heart attack and stroke ...

Low-dose aspirin significantly reduced colorectal cancer (CRC) recurrence among patients with PIK3CA hotspot mutations and ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

President Donald Trump announced that the FDA will notify physicians that the use of acetaminophen is associated with an ...